
Grove Biopharma scientific founder Nathan Gianneschi (L) and CEO Geoffrey Duyk
Exclusive: Chicago startup Grove Biopharma nabs $30M Series A
A small Northwestern University spinout attempting to develop a twist on biologics has pulled together a $30 million Series A.
The startup, named Grove Biopharma …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.